
- WORLD EDITIONAustraliaNorth AmericaWorld
February 23, 2023
Hygrovest Limited (ASX: HGV) ("HGV" or the “Company”) is an Australian-listed specialist investment company, which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.
Tender for Investment Manager
As foreshadowed in September 2022, the Independent Directors of HGV wishes to advise that it has undertaken a review of HGV’s operating structure to maximise the value of its investment portfolio having regard to the significant discount which HGV’s share price trades to its net asset value.
The HGV Board has concluded that:
1. The majority of HGV’s investments are unlisted minority interests in cannabis businesses which are more likely to be realised at their fair value in conjunction with a public listing or trade sale of the companies.
2. HGV is reliant on the parties who control these companies to execute a liquidity event.
3. The realisation of these investments is dependent on a material improvement in demand from potential acquirers (both trade and listed equity markets).
4. It is in the interest of HGV shareholders to continue to operate as an ASX listed investment company with an external investment manager to:
a) maximise the value of the current portfolio compared to book value;
b) access the expertise of the Investment Manager (the “Manager”) to maximise returns from redeployment of proceeds from sale of its portfolio; and
c) minimise the level of fixed costs in HGV’s cost structure.
5. HGV will undertake a process to appoint a Manager which is expected to be completed before 30 June 2023.
The current Investment Management Agreement with Parallax Ventures Inc. (“Parallax”) expires on 30 June 2023. HGV has invited Parallax to participate in the tender process to appoint a new Manager. Michael Curtis, a Non-Executive Director and Managing Partner of Parallax will abstain from participating in the appointment of the new Manager.
Realised gains from the sale of HGV’s investments would be distributed in accordance with HGV’s Dividend Policy1. HGV will also consider any proposals to use surplus capital to HGV shareholders in the event that HGV and its Manager are unable to deploy into attractive investment opportunities.
HGV expects the bulk of the Manager’s remuneration would continue to be linked to material increases in HGV’s share price and/or net asset value.
HGV will in due course update shareholders of the outcome of the tender process.
Click here for the full ASX Release
This article includes content from Hygrovest Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
HGV:AU
The Conversation (0)
12 January 2022
Hygrovest Limited
Building a globally diversified portfolio of companies in high-growth industries.
Building a globally diversified portfolio of companies in high-growth industries. Keep Reading...
06 January
Cannabis Market 2025 Year-End Review
2025 marked a turning point for investment in the cannabis sector, shifting the focus toward operational resilience and consolidation after a sluggish 2024. Key market drivers included an upswing in merger and acquisition (M&A) activity as stronger multi-state operators (MSOs) acquired... Keep Reading...
18 December 2025
Cannabis Market Forecast: Top Trends for Cannabis in 2026
The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
18 December 2025
Analysts React: Trump Signs Executive Order to Reschedule Cannabis
The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
15 December 2025
Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions
US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
14 November 2025
Hemp THC Recriminalization: A Blow to a Blooming Industry
A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
30 October 2025
Australia's Cannabis Import Quota Slashed Amid Surging Local Production
Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00






